Skip to main content

What the FDA labels say about taking them together

Carbamazepine and ensitrelvir

Ensitrelvir's FDA label of June 3, 2026 names carbamazepine in its drug interactions section; the carbamazepine labels PlainMeds reads (3) do not name ensitrelvir. The ensitrelvir label: “Co-administration is contraindicated due to potential loss of virologic response.”

Check it at the source: the carbamazepine FDA label on DailyMed (effective August 20, 2026, Novartis Pharmaceuticals Corporation); the ensitrelvir FDA label on DailyMed (effective June 3, 2026, Shionogi Inc.).

What does the carbamazepine label say about ensitrelvir?

Carbamazepine's label (effective August 20, 2026) and its 2 other brand-application labels do not name ensitrelvir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Tegretol), Novartis Pharmaceuticals Corporation, effective August 20, 2026 (SPL set 8d409411-aa9f-4f3a-a52c-fbcb0c3ec053), via openFDA; the full label on DailyMed

What does the ensitrelvir label say about carbamazepine?

Ensitrelvir label, drug interactions

Drug Class: Anticonvulsants; Drug (s) within Class: carbamazepine See, phenytoin; Effect on Drug Concentration: ↓ ensitrelvir; Clinical Comment: Co-administration is contraindicated due to potential loss of virologic response.

Source: FDA drug label (XOCOVA), Shionogi Inc., effective June 3, 2026 (SPL set 526acf60-abc3-2cc2-e063-6294a90affa6), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

42Carbamazepine generic labelers
0Ensitrelvir generic labelers
CarbamazepineEnsitrelvir
Labeled forBipolar disorder, Seizures and epilepsyCOVID-19
Boxed warningYesNo
Pharmacy cost (NADAC)$0.119 per tablet 200 mg tabletn/a
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?